Comprehensive curation of 38 GO annotations (57 GOA entries) for yeast SAS3, the catalytic subunit of the NuA3 histone acetyltransferase complex.
SAS3 is the catalytic subunit of NuA3, which exists in two forms:
NuA3a (Transcription Initiation)
- Composition: NTO1, SAS3, TAF14, YNG1, EAF6
- Mechanism: YNG1 PHD finger binds H3K4me3 at promoters
- Function: Acetylates H3K14 to promote transcription initiation
- Evidence: PMID:17157260, PMID:25104842
NuA3b (Transcription Elongation)
- Unique subunit: PDP3 (contains PWWP domain)
- Mechanism: PDP3 PWWP domain binds H3K36me3 at coding regions
- Function: Acetylates H3K14 to promote transcription elongation
- Evidence: PMID:25104842
Well-supported annotations with strong evidence:
| Category | Count | Quality |
|---|---|---|
| IDA (Direct Assay) | 9 | Highest |
| IMP (Mutant Phenotype) | 3 | Strong |
| IBA (Phylogenetic) | 8 | Moderate-High |
| IEA (Automated) | 16 | Lower |
| NAS (Non-curatable) | 2 | Valid |
| RCA (Reviewed Computational) | 1 | Valid |
All core functions supported by multiple evidence lines
GO:0005515 (protein binding) - IPI evidence code
GO:0006351 (DNA-templated transcription)
- Too broad/mechanistically misleading
- SAS3 regulates but doesn't catalyze transcription directly
- Recommendation: MODIFY to GO:0006357 (regulation of transcription by RNA polymerase II)
GO:0031507 (heterochromatin formation)
- Secondary to primary transcription activation function
- More specific terms available: GO:0031509, GO:0030466
- Recommendation: KEEP but mark as NON-CORE
GO:0000781 (chromosome, telomeric region)
- Logically valid but too general
- Specific functions better annotated by GO:0031509, GO:0030466
GO:0031507 (heterochromatin formation)
- Secondary function relative to transcription regulation
| Feature | SAS3 | SAS2 |
|---|---|---|
| Complex | NuA3 (two forms) | SAS (SAS2/SAS4/SAS5) |
| Primary Substrate | H3K14 | H4K16 + H3K14 |
| Primary Function | Transcription activation | Transcriptional silencing |
| Recognition Marks | H3K4me3, H3K36me3 | Telomeric regions |
| Secondary Function | HML silencing | Minimal |
| Family | MYST HATs | MYST HATs |
| Zinc Finger | C2HC type (essential) | C2HC type (essential) |
Key Distinction: SAS3 is primarily a transcriptional activator with regulated silencing roles, while SAS2 is primarily a silencing protein.
| File | Purpose |
|---|---|
| README-CURATION.md | This file - overview and summary |
| SAS3-CURATION-SUMMARY.md | Detailed curation summary with all annotation decisions |
| CURATION-REVIEW.txt | Quick reference - curation decisions by category |
| SAS3-ai-review.yaml | YAML annotation review (schema-compliant) |
| SAS3-goa.tsv | Original GOA file with all 57 annotations |
| SAS3-uniprot.txt | UniProt record (P34218) |
| Metric | Value | Assessment |
|---|---|---|
| Total Annotations Reviewed | 57 entries (38 unique) | Comprehensive |
| IDA (Direct Evidence) | 9 | High confidence |
| IMP (Mutant Evidence) | 3 | Strong evidence |
| IBA (Phylogenetic) | 8 | Conservative approach |
| IEA (Automated) | 16 | Lower confidence |
| Generic Terms | 7 removed | GO best practices |
| Over-annotations | 2 marked | Mechanistic refinement |
| Newly Proposed | 1 (H3K14 HAT) | Gap closure |
Overall Quality: HIGH - Multiple independent evidence sources for core functions; conservative treatment of phylogenetic inference; removal of uninformative generic terms.
Remove all GO:0005515 (protein binding) IPI annotations - These are uninformative and conflict with current GO guidelines. The complex membership annotations (GO:0033100, GO:1990467, GO:1990468) provide better mechanistic context.
Add GO:0036408 (histone H3K14 acetyltransferase activity) - Direct biochemical evidence supports this substrate-specific annotation, closing an important gap in functional specificity.
Modify GO:0006351 to GO:0006357 - More mechanistically accurate for SAS3's regulatory role in transcription.
Keep GO:0031507 as secondary annotation - Valid but less specific than GO:0031509 and GO:0030466.
For detailed annotation-by-annotation review, see SAS3-CURATION-SUMMARY.md